ipilimumab,nivolumab
bms
['able,(-kable),(-eable)', 'nivo', 'ipi/']
mucosal mel - closing remarks by dr jessica hassel from ; or = soc; ipi/nivo, pd-1 = reasonable options (soc). potential role for neoadj ipi/nivo in extensive cases. - adj setting: better local control. - adj pd1: not soc. definitely more data needed. 
Medical Oncologist - Clinical Fellow in #sarcoma and #melanoma at @pmcancercentre @uoft ???? - my tweets = my views